查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1855818

無細胞DNA（cfDNA）試劑盒全球市場報告（2025年）

Cell-Free DNA (cfDNA) Kits Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，無細胞DNA（cfDNA）試劑盒的市場規模迅速擴張，從2024年的16億美元成長到2025年的18億美元，複合年成長率達12.6%。這段時期的成長主要得益於診斷實驗室的增加、腫瘤學應用的日益普及、移植和婦科應用的廣泛使用，以及人工智慧在診斷領域日益成長的整合。

預計未來幾年，無細胞DNA（cfDNA）試劑盒市場將快速成長，到2029年市場規模將達到28.6億美元，複合年成長率（CAGR）為12.3%。預測期內的成長預計將受到以下因素的推動：數位聚合酵素鏈鎖反應（ DPRC）的日益普及、即時DPRC的廣泛應用、在其他疾病領域的應用拓展、診斷實驗室數量的成長以及對無創產前檢測需求的上升。預測期內的主要趨勢包括：單細胞基因組學的發展、自動化實驗室工作流程的整合、基於蛋白質組學的診斷技術的進步、代謝體學分析的創新以及無酶核酸檢測方法的開發。

預計未來幾年，遺傳疾病的日益普遍將推動無細胞DNA (cfDNA) 檢測試劑盒市場的成長。遺傳疾病是一種由一個或多個基因突變或染色體異常所導致的DNA改變所引起的疾病。這些疾病發生率的上升主要是由於生活方式的改變以及污染和不良飲食等環境因素造成的，這些因素會導致基因突變並加劇遺傳疾病。無細胞DNA (cfDNA) 檢測試劑盒透過分析血液和其他體液中存在的DNA片段，可以實現對遺傳異常的非侵入性早期檢測。這項技術能夠實現快速診斷，並幫助醫療保健提供者確定準確的治療方案。例如，美國疾病管制與預防中心 (CDC) 在2024年11月報告稱，美國大約每33名新生兒中就有1名患有先天性異常，其中許多與遺傳有關。因此，遺傳疾病日益普遍正在刺激cfDNA檢測試劑盒的需求。

cfDNA檢測試劑盒市場的主要企業正致力於開發採用基於數位聚合酵素鏈鎖反應（PCR）的絕對定量方法的創新產品，以提高cfDNA分析的靈敏度和準確性。基於數位PCR的絕對定量方法能夠更準確地檢測低頻基因突變，並提高檢測結果的一致性，使其適用於癌症診斷、產前檢測和移植排斥反應監測等重要應用。例如，2024年6月，總部位於匈牙利的分子診斷公司Omixon推出了HoloGRAFT ONE，這是一款僅供研究使用的試劑盒，旨在監測移植後供體來源的遊離DNA（dd-cfDNA）。該試劑盒利用專有的遺傳標記和數位PCR技術來區分供體DNA和受體DNA，並透過拷貝數變異來測量dd-cfDNA的絕對和相對含量。這項創新檢測的目標是為臨床醫生提供準確的cfDNA數據，從而實現移植排斥反應的早期檢測、改善患者監測並支持個人化的移植後護理。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅，以及新冠疫情及其復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球無細胞DNA（cfDNA）試劑盒：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 終端用戶產業分析
  • 全球無細胞DNA（cfDNA）試劑盒市場：成長率分析
  • 全球無細胞DNA（cfDNA）試劑盒市場表現：規模與成長，2019-2024年
  • 全球無細胞DNA（cfDNA）試劑盒市場預測：規模與成長，2024-2029年，2034年
  • 全球無細胞DNA（cfDNA）試劑盒：潛在市場規模（TAM）

第6章 市場細分

  • 全球無細胞DNA（cfDNA）試劑盒市場按產品類型、性能和預測分類，2019-2024年、2024-2029年、2034年
  • 血漿遊離DNA (cfDNA) 試劑盒
  • 血清遊離DNA (cfDNA) 檢測試劑盒
  • 尿液無細胞DNA (cfDNA) 檢測試劑盒
  • 其他產品
  • 全球無細胞DNA（cfDNA）試劑盒市場：依技術、效能和預測分類，2019-2024年、2024-2029年、2034年
  • 次世代定序儀（NGS）
  • 聚合酵素鏈鎖反應（PCR）
  • 微陣列技術
  • 數位聚合酵素鏈鎖反應（PCR）
  • 全球無細胞DNA（cfDNA）試劑盒市場：按應用、性能和預測分類，2019-2024年、2024-2029年、2034年
  • 癌症診斷劑
  • 產前檢查
  • 監測移植排斥反應
  • 非侵入性疾病檢測
  • 全球無細胞DNA（cfDNA）試劑盒市場按分銷管道分類：實際數據和預測，2019-2024年、2024-2029年、2034年
  • 直銷
  • 零售藥房
  • 線上銷售
  • 經銷商
  • 全球無細胞DNA（cfDNA）試劑盒市場按最終用戶、性能和預測分類，2019-2024年、2024-2029年、2034年
  • 醫院
  • 研究所
  • 診斷實驗室
  • 學術機構
  • 全球無細胞DNA (cfDNA) 試劑盒市場：細分市場 血漿無細胞DNA試劑盒：按類型、性能和預測，2019-2024年、2024-2029年、2034年
  • 單鏈DNA試劑盒
  • 雙鏈DNA試劑盒
  • 高靈敏度DNA檢測試劑盒
  • 快速DNA萃取試劑盒
  • 全球無細胞DNA (cfDNA) 試劑盒市場：細分市場 血清無細胞DNA試劑盒：按類型、性能和預測，2019-2024年、2024-2029年、2034年
  • 小規模DNA生產試劑盒
  • 高產量DNA試劑盒
  • 自動化DNA檢測試劑盒
  • 手動DNA萃取試劑盒
  • 全球無細胞DNA (cfDNA) 試劑盒市場：細分市場 尿液無細胞DNA試劑盒：按類型、性能和預測，2019-2024年、2024-2029年、2034年
  • 早期檢測DNA試劑盒
  • 濃縮DNA試劑盒
  • 高純度DNA試劑盒
  • 長期穩定DNA試劑盒
  • 全球無細胞DNA（cfDNA）試劑盒市場：按產品、類型、性能和預測進行細分，2019-2024年、2024-2029年、2034年
  • 唾液DNA檢測試劑盒
  • 腦脊髓液DNA檢測試劑盒
  • 羊水DNA檢測試劑盒
  • 組織來源DNA試劑盒

第7章 區域和國家分析

  • 全球無細胞DNA（cfDNA）試劑盒市場：按地區、性能和預測分類，2019-2024年、2024-2029年、2034年
  • 全球無細胞DNA（cfDNA）試劑盒市場按國家/地區、性能和預測分類，2019-2024年、2024-2029年、2034年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 無細胞DNA（cfDNA）試劑盒市場：競爭格局
  • 無細胞DNA（cfDNA）試劑盒市場：公司簡介
    • F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • QIAGEN NV
  • Natera Inc.
  • Myriad Genetics Inc.
  • Guardant Health Inc.
  • Bioneer Corporation
  • Streck Inc.
  • Freenome Holdings Inc.
  • GRAIL Inc.
  • Zymo Research Corporation
  • Geneseeq Technology Inc
  • Covaris LLC
  • Active Motif Inc.
  • Norgen Biotek Corp
  • AMSBIO LLC
  • EpiGentek Group Inc.

第32章 全球市場競爭基準化分析與儀錶板

第33章 重大併購

第34章 近期市場趨勢

第35章：高潛力市場國家、細分市場與策略

  • 無細胞DNA（cfDNA）試劑盒市場2029：提供新機會的國家
  • 無細胞DNA（cfDNA）試劑盒市場展望（2029）：新興細分市場機會
  • 無細胞DNA（cfDNA）試劑盒市場2029年：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章附錄

簡介目錄
Product Code: r38467

Cell-free DNA (cfDNA) kits are laboratory tools designed to isolate and analyze fragmented DNA circulating in blood or other body fluids. They support non-invasive genetic testing by providing high-quality DNA for applications such as prenatal screening, cancer diagnostics, and transplant monitoring. These kits simplify sample preparation and enhance accuracy in downstream molecular analysis.

The primary product types in the cell-free DNA (cfDNA) kits market include plasma cfDNA kits, serum cfDNA kits, urine cfDNA kits, and others. Plasma cfDNA kits are designed to isolate and analyze DNA fragments circulating in plasma, the liquid component of blood. Key technologies include next-generation sequencing (NGS), polymerase chain reaction (PCR), microarray technology, and digital PCR. Major applications encompass cancer diagnostics, prenatal testing, transplant rejection monitoring, and non-invasive disease detection. Distribution channels consist of direct sales, retail pharmacies, online platforms, and distributors, while end users include hospitals, research laboratories, diagnostic laboratories, and academic institutions.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The cell-free DNA (cfDNA) market research report is one of a series of new reports from The Business Research Company that provides cell-free DNA (cfDNA) market statistics, including cell-free DNA (cfDNA) industry global market size, regional shares, competitors with a cell-free DNA (cfDNA) market share, detailed cell-free DNA (cfDNA) market segments, market trends and opportunities, and any further data you may need to thrive in the cell-free DNA (cfDNA) industry. The cell-free DNA (cfDNA) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cell-free DNA (cfDNA) kits market size has grown rapidly in recent years. It will grow from $1.60 billion in 2024 to $1.80 billion in 2025 at a compound annual growth rate (CAGR) of 12.6%. Growth in the historic period was driven by the increasing number of diagnostic laboratories, greater adoption of oncology applications, wider use in transplantation and gynecology applications, and rising integration of artificial intelligence in diagnostics.

The cell-free DNA (cfDNA) kits market size is expected to see rapid growth in the next few years. It will grow to $2.86 billion in 2029 at a compound annual growth rate (CAGR) of 12.3%. Growth in the forecast period is expected to be supported by rising adoption of digital polymerase chain reaction, increased use of real-time polymerase chain reaction, expanding applications in other disease areas, growth in the number of diagnostic laboratories, and higher demand for non-invasive prenatal testing. Key trends anticipated for the forecast period include advancements in single-cell genomics, integration of automated laboratory workflows, progress in proteomics-based diagnostics, innovation in metabolomics analysis, and the development of enzyme-free nucleic acid detection methods.

The increasing prevalence of genetic disorders is expected to drive the growth of the cell-free DNA (cfDNA) kits market in the coming years. Genetic disorders are medical conditions caused by alterations in a person's DNA, which can result from mutations in one or more genes, or chromosomal abnormalities. The rising occurrence of these disorders is largely due to lifestyle changes and environmental factors such as pollution and poor diet, which can either cause genetic mutations or worsen inherited conditions. Cell-free DNA (cfDNA) kits enable early, non-invasive detection of genetic abnormalities by analyzing DNA fragments present in blood or other body fluids. This technology facilitates quicker diagnoses and allows healthcare providers to make accurate treatment decisions. For example, the Centers for Disease Control and Prevention (CDC), a U.S.-based government agency, reported in November 2024 that about 1 in every 33 newborns in the U.S. is born with a birth defect, many of which are genetically related. As a result, the increasing prevalence of genetic disorders is fueling demand for cfDNA kits.

Leading companies in the cfDNA kits market are concentrating on developing innovative products that use digital polymerase chain reaction (PCR)-based absolute quantification to enhance the sensitivity and accuracy of cfDNA analysis. Digital PCR-based absolute quantification allows for the precise detection of low-frequency genetic variants with improved consistency, making it suitable for critical applications such as cancer diagnostics, prenatal testing, and monitoring transplant rejection. For example, in June 2024, Omixon, a molecular diagnostics company based in Hungary, introduced HoloGRAFT ONE, a research-use-only kit designed to monitor donor-derived cell-free DNA (dd-cfDNA) post-transplant. This kit utilizes proprietary genetic markers and digital PCR to differentiate donor DNA from the recipient's DNA, measuring both absolute and relative amounts of dd-cfDNA through copy-number variants. The goal of this innovative test is to enable the early detection of transplant rejection, improve patient monitoring, and support personalized post-transplant care by providing clinicians with precise cfDNA data.

In February 2022, Labcorp Holdings Inc., a U.S.-based life sciences company, acquired Personal Genome Diagnostics Inc. for an undisclosed amount. This acquisition allows Labcorp to integrate Personal Genome Diagnostics' advanced genomic technologies to enhance its cancer diagnostic offerings and bolster its precision medicine capabilities. Personal Genome Diagnostics Inc. is a U.S.-based company specializing in cell-free DNA (cfDNA) kits, with a focus on circulating tumor DNA (ctDNA) for cancer research and diagnostics.

Major players in the cell-free DNA (cfDNA) kits market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V, Natera Inc., Myriad Genetics Inc., Guardant Health Inc., Bioneer Corporation, Streck Inc., Freenome Holdings Inc., GRAIL Inc., Zymo Research Corporation, Geneseeq Technology Inc, Covaris LLC, Active Motif Inc., Norgen Biotek Corp, AMSBIO LLC, EpiGentek Group Inc., Paragon Genomics Inc., Suzhou Beaver Biomedical Engineering.

North America was the largest region in the cell-free DNA (cfDNA) kits market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in cell-free DNA (cfDNA) kits report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the cell-free DNA (cfDNA) kits market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cell-free DNA (cfDNA) kits market consists of revenues earned by entities by providing services such as purification services, bulk services, quality control (QC) services, data integration services, and custom biomarker discovery services. The market value includes the value of related goods sold by the service provider or included within the service offering. The cell-free DNA (cfDNA) kits market also includes sales of plasma separation consumables, liquid biopsy assay kits, serum preparation kits, concentration kits, and bisulfite conversion and methylation kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cell-Free DNA (cfDNA) Kits Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cell-free dna (cfdna) kits market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cell-free dna (cfdna) kits ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cell-free dna (cfdna) kits market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Plasma Cell-Free DNA (Cfdna) Kits; Serum Cell-Free DNA (Cfdna) Kits; Urine Cell-Free DNA (Cfdna) Kits; Other Products
  • 2) By Technology: Next-Generation Sequencing (NGS); Polymerase Chain Reaction (PCR); Microarray Technology; Digital Polymerase Chain Reaction(PCR)
  • 3) By Application: Cancer Diagnostics; Prenatal Testing; Transplant Rejection Monitoring; Non-Invasive Disease Detection
  • 4) By Distribution Channel: Direct Sales; Retail Pharmacies; Online Sales; Distributors
  • 5) By End User: Hospitals; Research Laboratories; Diagnostic Laboratories; Academic Institutions
  • Subsegments:
  • 1) By Plasma Cell-Free DNA Kits: Single-Stranded DNA Kits; Double-Stranded DNA Kits; High-Sensitivity DNA Kits; Rapid Extraction DNA Kits
  • 2) By Serum Cell-Free DNA Kits: Low-Volume DNA Kits; High-Yield DNA Kits; Automated DNA Kits; Manual Extraction DNA Kits
  • 3) By Urine Cell-Free DNA Kits: Early Detection DNA Kits; Concentration DNA Kits; High-Purity DNA Kits; Long-Term Stability DNA Kits
  • 4) By Other Products: Saliva DNA Kits; Cerebrospinal Fluid DNA Kits; Amniotic Fluid DNA Kits; Tissue-Derived DNA Kits
  • Companies Mentioned: F. Hoffmann-La Roche Ltd; Thermo Fisher Scientific Inc.; Agilent Technologies Inc.; Illumina Inc.; Bio-Rad Laboratories Inc.; QIAGEN N.V; Natera Inc.; Myriad Genetics Inc.; Guardant Health Inc.; Bioneer Corporation; Streck Inc.; Freenome Holdings Inc.; GRAIL Inc.; Zymo Research Corporation; Geneseeq Technology Inc; Covaris LLC; Active Motif Inc.; Norgen Biotek Corp; AMSBIO LLC; EpiGentek Group Inc.; Paragon Genomics Inc.; Suzhou Beaver Biomedical Engineering.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cell-Free DNA (cfDNA) Kits Market Characteristics

3. Cell-Free DNA (cfDNA) Kits Market Trends And Strategies

4. Cell-Free DNA (cfDNA) Kits Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Cell-Free DNA (cfDNA) Kits Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Cell-Free DNA (cfDNA) Kits PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Cell-Free DNA (cfDNA) Kits Market Growth Rate Analysis
  • 5.4. Global Cell-Free DNA (cfDNA) Kits Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Cell-Free DNA (cfDNA) Kits Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Cell-Free DNA (cfDNA) Kits Total Addressable Market (TAM)

6. Cell-Free DNA (cfDNA) Kits Market Segmentation

  • 6.1. Global Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Plasma Cell-Free DNA (Cfdna) Kits
  • Serum Cell-Free DNA (Cfdna) Kits
  • Urine Cell-Free DNA (Cfdna) Kits
  • Other Products
  • 6.2. Global Cell-Free DNA (cfDNA) Kits Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Next-Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • Microarray Technology
  • Digital Polymerase Chain Reaction(PCR)
  • 6.3. Global Cell-Free DNA (cfDNA) Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cancer Diagnostics
  • Prenatal Testing
  • Transplant Rejection Monitoring
  • Non-Invasive Disease Detection
  • 6.4. Global Cell-Free DNA (cfDNA) Kits Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Direct Sales
  • Retail Pharmacies
  • Online Sales
  • Distributors
  • 6.5. Global Cell-Free DNA (cfDNA) Kits Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Research Laboratories
  • Diagnostic Laboratories
  • Academic Institutions
  • 6.6. Global Cell-Free DNA (cfDNA) Kits Market, Sub-Segmentation Of Plasma Cell-Free DNA Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Stranded DNA Kits
  • Double-Stranded DNA Kits
  • High-Sensitivity DNA Kits
  • Rapid Extraction DNA Kits
  • 6.7. Global Cell-Free DNA (cfDNA) Kits Market, Sub-Segmentation Of Serum Cell-Free DNA Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Low-Volume DNA Kits
  • High-Yield DNA Kits
  • Automated DNA Kits
  • Manual Extraction DNA Kits
  • 6.8. Global Cell-Free DNA (cfDNA) Kits Market, Sub-Segmentation Of Urine Cell-Free DNA Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Early Detection DNA Kits
  • Concentration DNA Kits
  • High-Purity DNA Kits
  • Long-Term Stability DNA Kits
  • 6.9. Global Cell-Free DNA (cfDNA) Kits Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Saliva DNA Kits
  • Cerebrospinal Fluid DNA Kits
  • Amniotic Fluid DNA Kits
  • Tissue-Derived DNA Kits

7. Cell-Free DNA (cfDNA) Kits Market Regional And Country Analysis

  • 7.1. Global Cell-Free DNA (cfDNA) Kits Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Cell-Free DNA (cfDNA) Kits Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cell-Free DNA (cfDNA) Kits Market

  • 8.1. Asia-Pacific Cell-Free DNA (cfDNA) Kits Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Cell-Free DNA (cfDNA) Kits Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Cell-Free DNA (cfDNA) Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cell-Free DNA (cfDNA) Kits Market

  • 9.1. China Cell-Free DNA (cfDNA) Kits Market Overview
  • 9.2. China Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Cell-Free DNA (cfDNA) Kits Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Cell-Free DNA (cfDNA) Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cell-Free DNA (cfDNA) Kits Market

  • 10.1. India Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Cell-Free DNA (cfDNA) Kits Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Cell-Free DNA (cfDNA) Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cell-Free DNA (cfDNA) Kits Market

  • 11.1. Japan Cell-Free DNA (cfDNA) Kits Market Overview
  • 11.2. Japan Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Cell-Free DNA (cfDNA) Kits Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Cell-Free DNA (cfDNA) Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cell-Free DNA (cfDNA) Kits Market

  • 12.1. Australia Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Cell-Free DNA (cfDNA) Kits Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Cell-Free DNA (cfDNA) Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cell-Free DNA (cfDNA) Kits Market

  • 13.1. Indonesia Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Cell-Free DNA (cfDNA) Kits Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Cell-Free DNA (cfDNA) Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cell-Free DNA (cfDNA) Kits Market

  • 14.1. South Korea Cell-Free DNA (cfDNA) Kits Market Overview
  • 14.2. South Korea Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Cell-Free DNA (cfDNA) Kits Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Cell-Free DNA (cfDNA) Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cell-Free DNA (cfDNA) Kits Market

  • 15.1. Western Europe Cell-Free DNA (cfDNA) Kits Market Overview
  • 15.2. Western Europe Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Cell-Free DNA (cfDNA) Kits Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Cell-Free DNA (cfDNA) Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cell-Free DNA (cfDNA) Kits Market

  • 16.1. UK Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Cell-Free DNA (cfDNA) Kits Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Cell-Free DNA (cfDNA) Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cell-Free DNA (cfDNA) Kits Market

  • 17.1. Germany Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Cell-Free DNA (cfDNA) Kits Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Cell-Free DNA (cfDNA) Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cell-Free DNA (cfDNA) Kits Market

  • 18.1. France Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Cell-Free DNA (cfDNA) Kits Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Cell-Free DNA (cfDNA) Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cell-Free DNA (cfDNA) Kits Market

  • 19.1. Italy Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Cell-Free DNA (cfDNA) Kits Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Cell-Free DNA (cfDNA) Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cell-Free DNA (cfDNA) Kits Market

  • 20.1. Spain Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Cell-Free DNA (cfDNA) Kits Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Cell-Free DNA (cfDNA) Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cell-Free DNA (cfDNA) Kits Market

  • 21.1. Eastern Europe Cell-Free DNA (cfDNA) Kits Market Overview
  • 21.2. Eastern Europe Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Cell-Free DNA (cfDNA) Kits Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Cell-Free DNA (cfDNA) Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cell-Free DNA (cfDNA) Kits Market

  • 22.1. Russia Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Cell-Free DNA (cfDNA) Kits Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Cell-Free DNA (cfDNA) Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cell-Free DNA (cfDNA) Kits Market

  • 23.1. North America Cell-Free DNA (cfDNA) Kits Market Overview
  • 23.2. North America Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Cell-Free DNA (cfDNA) Kits Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Cell-Free DNA (cfDNA) Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cell-Free DNA (cfDNA) Kits Market

  • 24.1. USA Cell-Free DNA (cfDNA) Kits Market Overview
  • 24.2. USA Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Cell-Free DNA (cfDNA) Kits Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Cell-Free DNA (cfDNA) Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cell-Free DNA (cfDNA) Kits Market

  • 25.1. Canada Cell-Free DNA (cfDNA) Kits Market Overview
  • 25.2. Canada Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Cell-Free DNA (cfDNA) Kits Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Cell-Free DNA (cfDNA) Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cell-Free DNA (cfDNA) Kits Market

  • 26.1. South America Cell-Free DNA (cfDNA) Kits Market Overview
  • 26.2. South America Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Cell-Free DNA (cfDNA) Kits Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Cell-Free DNA (cfDNA) Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cell-Free DNA (cfDNA) Kits Market

  • 27.1. Brazil Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Cell-Free DNA (cfDNA) Kits Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Cell-Free DNA (cfDNA) Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cell-Free DNA (cfDNA) Kits Market

  • 28.1. Middle East Cell-Free DNA (cfDNA) Kits Market Overview
  • 28.2. Middle East Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Cell-Free DNA (cfDNA) Kits Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Cell-Free DNA (cfDNA) Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cell-Free DNA (cfDNA) Kits Market

  • 29.1. Africa Cell-Free DNA (cfDNA) Kits Market Overview
  • 29.2. Africa Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Cell-Free DNA (cfDNA) Kits Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Cell-Free DNA (cfDNA) Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cell-Free DNA (cfDNA) Kits Market Competitive Landscape And Company Profiles

  • 30.1. Cell-Free DNA (cfDNA) Kits Market Competitive Landscape
  • 30.2. Cell-Free DNA (cfDNA) Kits Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Cell-Free DNA (cfDNA) Kits Market Other Major And Innovative Companies

  • 31.1. QIAGEN N.V
  • 31.2. Natera Inc.
  • 31.3. Myriad Genetics Inc.
  • 31.4. Guardant Health Inc.
  • 31.5. Bioneer Corporation
  • 31.6. Streck Inc.
  • 31.7. Freenome Holdings Inc.
  • 31.8. GRAIL Inc.
  • 31.9. Zymo Research Corporation
  • 31.10. Geneseeq Technology Inc
  • 31.11. Covaris LLC
  • 31.12. Active Motif Inc.
  • 31.13. Norgen Biotek Corp
  • 31.14. AMSBIO LLC
  • 31.15. EpiGentek Group Inc.

32. Global Cell-Free DNA (cfDNA) Kits Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cell-Free DNA (cfDNA) Kits Market

34. Recent Developments In The Cell-Free DNA (cfDNA) Kits Market

35. Cell-Free DNA (cfDNA) Kits Market High Potential Countries, Segments and Strategies

  • 35.1 Cell-Free DNA (cfDNA) Kits Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Cell-Free DNA (cfDNA) Kits Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Cell-Free DNA (cfDNA) Kits Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer